Dr. Mark Alan McCurdy, MD

Dr. McCurdy practices at Texas Oncology PA in Fort Worth, Texas.

Dr. McCurdy's NPI, 1255327383, was assigned on September 23, 2005. Dr. McCurdy graduated from Baylor College Of Medicine in 1994. Dr. McCurdy holds Texas license K0345.

Dr. McCurdy's primary practice is Texas Oncology PA, at 500 S Henderson St, Fort Worth, TX 76104 in Tarrant County. The practice phone is (972) 997-8000.

Dr. McCurdy's primary practice is Texas Oncology PA in Fort Worth, Texas. Dr. McCurdy is also affiliated with Baylor Scott & White All Saints Medical Center - Fort Worth. The medical group on file is Texas Oncology. Dmand AI also links Dr. McCurdy to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McCurdy practices, 5 sites in all. Vendor and product names are available with a free account.

Urology is Dr. McCurdy's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. McCurdy is board certified in urology by the American Board of Urology. Dr. McCurdy is licensed in Texas.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney stone disease, pelvic prolapse and prostate cancer among the conditions Dr. McCurdy treats.

CMS data shows 2,392 Medicare services from Dr. McCurdy across 24 procedure codes in 2024, for 792 Medicare patients. Medicare paid $197,044 for them. Every service was in an office.

CMS counts 792 Medicare patients who saw Dr. McCurdy in 2024. The largest group is 65 to 74, with 398 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 2% are also on Medicaid. Their average risk score is 1.19, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. McCurdy's median patient age at 71, with 16% women.

In 2024, Dr. McCurdy wrote 3,394 Medicare Part D claims for 973 patients. 93% of them were for generic drugs. CMS names the drug for 3,274 of them, across 26 drugs with 11 or more claims each, at $222,509 in total drug cost. In 2023, CMS named 3,381 claims across 26 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. McCurdy for performance year 2024, reported through an alternative payment model (APM). Dr. McCurdy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 11 procedures of prostate resection by Dr. McCurdy, more than 60% of the clinicians it reports for that procedure.

Dmand AI links 5 papers to Dr. McCurdy in 2021. The most frequent topics are Prostatic Neoplasms, Adenoviridae and Flow Cytometry. Dr. McCurdy's most frequent co-authors are Howard L. Adler, MD, Justin M. Albani, MD and Murali Chintagumpala, MD.

CMS Open Payments shows 343 general payments to Dr. McCurdy from 57 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 88% of the total. PROCEPT BioRobotics Corporation paid the most, $1,203.

Dmand AI lists 1 award for Dr. McCurdy, most recently CMS Stage 1 2012 in 2012.

Dr. McCurdy graduated from Baylor College Of Medicine in 1994.

Dr. McCurdy is in network with 23 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.